Generalisability of clinical trials of newer glucose-lowering drugs to real-world people with type 2 diabetes (2023)
Attributed to:
Real-world treatment effectiveness in people with type 2 diabetes: Maximising the applicability of clinical trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract